Navigation Links
On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
Date:9/13/2007

for angioplasty, and it was successful just 65 percent of the time. Ten percent of patients experienced a serious complication, and approximately six percent of patients needed emergency bypass surgery.

Today, approximately two-thirds of patients with coronary artery disease are candidates for angioplasty, stenting and other catheter-based treatments. The treatments are successful in 98 percent of patients, and major complications occur in only 1.5 percent of cases. Just one patient in 1,000 needs emergency bypass surgery.

The 30-year legacy of interventional cardiology also includes pioneering evidence-based medicine -- the discipline of recording and evaluating the outcomes of various procedures to identify those that produce the best results for patients. "Interventional cardiology has led the medical field in taking an evidence-based approach and establishing best practice guidelines that enable cardiologists around the world to know what procedures yield the best patient outcomes," said Dr. Bailey.

Dr. Gruentzig tracked patient outcomes by hand, keeping notes on a chalkboard to record results and analyze trends, according to Dr. Bailey. "Compared with the computer tracking and reporting we do today, his methods may seem like using an abacus. But they laid the foundation for the widespread use of evidence-based medicine.

"Over the years, interventional cardiology has faced challenges," said Dr. Bailey. "In each case, we have responded with innovation, and then rigorously applied the discipline of evidence-based medicine to ensure the safety and efficacy of our solutions."

Refinements in catheters and balloons have been continuous. But dramatically improved patient outcomes are attributed to two other major advancements:

-- The bare metal stent, approved by the U.S. Food and Drug

Administration in 1994, was designed to address the problem of sudden

collapse of an artery following angioplasty. Arteries that
'/>"/>

SOURCE The Society for Cardiovascular Angiography and
Interventions
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Statins reduce risks for angioplasty patients
2. Cholesterol Drug Helps After Angioplasty
3. Angioplasty Should be the Standard
4. The Success Rate Of Angioplasty In Female Patients Low
5. Angioplasty The Much Preferred Treatment Of Choice For Heart Attacks
6. Angioplasty death risk reduced by doubling drug dose
7. Angioplasty death risk reduced by doubling drug dose
8. A ray of hope in Angioplasty dilemma
9. Angioplasty plus stenting better than thrombolysis for elderly patients with AMI
10. Patients Fare Better With Doctors Who Do More Angioplasty Procedures
11. Researchers Begin Study To Find Out If Angioplasty Can Be Safely Done In Smaller Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... 2015 HomeCEUConnection.com is proud ... extra savings on their nutrition CEUs. To ... and nutrition, HomeCEUConnection.com is offering 10% off ... code, NUTRITION2015 . , High Quality ... HomeCEUConnection.com provides high-quality continuing education courses for ...
(Date:3/5/2015)... March 05, 2015 On March 2, ... Augmentation, Labiaplasty on the Rise, Plastic Surgeons Say,” that ... American Society for Aesthetic Plastic Surgery and ... groups reported a year-over-year doubling of surgical butt augmentations ... quoted in the article, this increase can be attributed ...
(Date:3/5/2015)... March 05, 2015 In honor of ... shatter myths about drug and alcohol abuse in schools ... a Fact Sheet with information on some of the ... 2010 by the National Institute on Drug Abuse, this ... aims to counteract the illusions that teens and young ...
(Date:3/5/2015)... At the 7th Annual Mississippi Addiction Conference ... met today in Jackson, Mississippi to listen to keynote ... numerous respected speakers will be William S. Jacobs, ... pain medications have had in today’s opiate overdose and ... is hard to believe that much of the current ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:The Kim Kardashian and Jennifer Lopez Effect: Butt Augmentations Double from 2013 to 2014 2Health News:A Forever Recovery Issues New Tips for Sobriety for National Drug Facts Week 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3
... Pinnacle health systems already achieving positive results following ... April 3 CentraState and Pinnacle health ... information technology to improve nursing practice as part ... www.siemens.com/healthcare ) experience at ...
... and Distribution Workflow Solution Provides Final Reports in ... UltraRAD Corp. and StructuRad LLC announce that ... now in production at Valor Network, Inc. The ... image management and reporting based on StructuRad,s StudyManager ...
... Foods to Donate $250,000 - 1.75 million meals ... Relief OrganizationOMAHA, Neb., April 3 Healthy Choice, ... completely reinvented - focusing on what people want ... for the frozen entree category. After 20 years ...
... Calif., April 3 IDM Pharma, Inc. (Nasdaq: ... of innovative cancer products, including MEPACT(R) (known as mifamurtide ... Europe for the treatment of osteosarcoma, today announced that ... 31, 2008, included in the Annual Report on Form ...
... Betsy Vasquez, MD announced today the opening of AVIE!, their new medical ... Plaza II. , ... Leesburg, VA (PRWEB) April 3, 2009-- Kim ... and Laser Center is officially open for business at their Fort Evans ...
... 2 As news emerged that Gov. Kathleen ... has been postponed until the end of April, ... Brownback and Pat Roberts to reject the nomination.(Logo: ... on "Senatorial Courtesy" -- the longstanding Senate tradition ...
Cached Medicine News:Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 2Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 3Health News:Designing the Care-Planning Process to Guide Evidence-Based Practice 4Health News:UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster 2Health News:UltraRAD and StructuRad Add Valor Network, Inc. to Client Roster 3Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 2Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 3Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 4Health News:IDM Pharma Complies With NASDAQ Marketplace Rule 4350(b)(1)(B) and Announces Filing of Annual Report on Form 10-K for 2008 Fiscal Year Containing Audit Opinion With Going Concern Qualification 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 2Health News:Top Medical Team Launches AVIE! Medspa & Laser Center in Leesburg, VA 3Health News:A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed 2
(Date:3/5/2015)... HAMPTON, N.J. , March 5, 2015 ... MNK ), a leading global specialty biopharmaceutical company, and ... that they have entered into a definitive agreement under ... from a Madison Dearborn -led investor group in ... Subject to customary closing conditions, the parties expect ...
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Global Rising Stars Outlook 2015" report to ... diseases are being sought after with fresh vigor as ... field which is poised to bring a paradigm change ... decades is the Stem cell therapy/Regenerative Medicine space. ...
(Date:3/5/2015)... 5, 2015 According to a ... Product (Systems and Disposables), by Type (Invasive, Minimally Invasive, ... and Ambulatory Sites) - Analysis & Global Forecast to ... expected to reach $1,107.4 Million by 2019 from $887.8 ... a CAGR of 4.5% during the forecast period. ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Global Pharma Rising Stars Outlook 2015 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 2Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 3Hemodynamic Monitoring Systems Market Worth $1,107.4 Million by 2019 4
... DUBLIN, Calif., June 16 SuperGen Inc.,(Nasdaq: ... to the discovery, rapid,development and commercialization of ... announced at the 13th Congress of the,European ... its JAK2 kinase inhibitor, prevents tumor cell ...
... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
Cached Medicine Technology:SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2
Angled 45 degree shafts with 10.5 mm tying and 1 mm of tip crisscross serrated. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.2 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Straight, 7 mm tying platform. Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Angled Castroviejo handle. Manufactured in titanium. Overall length 4.2 inches....
Medicine Products: